CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
|
Dec. 31, 2025
USD ($)
|
Dec. 31, 2024
USD ($)
|
Dec. 31, 2023
USD ($)
|
|
| Foreign currency translation adjustments, tax portion | $ 0 | $ 0 | $ 0 |
| Unrealized losses on available-for-sale investment, net of tax | 0 | 0 | 0 |
| Share-based compensation | 25,800 | 23,200 | 31,979 |
| Cost of revenues | |||
| Share-based compensation | 3,927 | 1,720 | 3,575 |
| Research and development expenses | |||
| Share-based compensation | 9,418 | 12,408 | 19,415 |
| Sales and marketing expenses | |||
| Share-based compensation | 1,383 | 615 | 797 |
| General and administrative expenses | |||
| Share-based compensation | $ 11,072 | $ 8,457 | $ 8,192 |
| Class A common shares | |||
| Number of common shares represented by each ADS | 20 | 20 | 20 |